These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4067813)

  • 1. Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent. II. Influence of the route of administration on bioavailability in dogs.
    Yoshimura M; Kojima J; Ito T; Fujii M; Suzuki J
    J Pharmacobiodyn; 1985 Jul; 8(7):503-12. PubMed ID: 4067813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent. I. Studies on interspecies variation in laboratory animals.
    Yoshimura M; Kojima J; Ito T; Suzuki J
    J Pharmacobiodyn; 1985 Sep; 8(9):738-50. PubMed ID: 4087134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol.
    Kabuto S; Kimata H; Yonemitsu M; Koide T; Nakao H; Suzuki J
    Arzneimittelforschung; 1985; 35(11):1674-9. PubMed ID: 3937533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 2nd communication: A single oral administration of [14C]nipradilol to spontaneously hypertensive rats.
    Kimata H; Kabuto S; Yonemitsu M; Koide T; Nakao H; Suzuki J
    Arzneimittelforschung; 1985; 35(11):1680-4. PubMed ID: 4091870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of propranolol in the dog.
    Tse FL; Sanders TM; Reo JP
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphation and glucuronidation of xamoterol in the dog: dose dependence and site of sulphation.
    Groen K; Warrander A; Miles GS; Booth BS; Mulder GJ
    Xenobiotica; 1988 May; 18(5):511-8. PubMed ID: 2969648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear first-pass metabolism of propranolol in the rat.
    Suzuki T; Ohkuma T; Isozaki S
    J Pharmacobiodyn; 1981 Feb; 4(2):131-41. PubMed ID: 7277199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of D-propranolol following oral, intra-arterial and intraportal administration: contrasting effects of oral glucose pretreatment.
    Chow HH; Lalka D
    Biopharm Drug Dispos; 1993 Apr; 14(3):217-31. PubMed ID: 8490110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the route of administration on the mean hepatic extraction ratio of propranolol in the rat.
    Suzuki T; Isozaki S; Ohkuma T; Rikihisa T
    J Pharmacobiodyn; 1980 Nov; 3(11):603-11. PubMed ID: 7241334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH; Lee MG
    Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of absorption, intestinal and hepatic first pass effect in a chronic dog model.
    Lemaire M; Bodoky A; Heberer M; Niederberger W
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():132-5. PubMed ID: 1820867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.
    Ishizaki T; Ohnishi A; Sasaki T; Kushida K; Horai Y; Chiba K; Suganuma T
    Eur J Clin Pharmacol; 1983; 25(1):95-101. PubMed ID: 6137389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog.
    Cotler S; Chen S; Macasieb T; Colburn WA
    Drug Metab Dispos; 1984; 12(2):143-7. PubMed ID: 6144477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent presystemic elimination of propranolol due to hepatic first-pass metabolism in rats.
    Iwamoto K; Watanabe J
    J Pharm Pharmacol; 1985 Nov; 37(11):826-8. PubMed ID: 2867168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of partial absorption of nicardipine by routes other than the hepato-portal system after oral administration in rats.
    Mizumura J; Watari N; Higuchi S
    J Pharm Pharmacol; 1998 Jul; 50(7):775-81. PubMed ID: 9720627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.